Thanks to a new technology, the diagnosis of brain cancer undergoes a breakthrough. The credit goes to cancer diagnostics company and University of Strathclyde Dxcover spin-out company. The company has indeed launched the liquid biopsy Dxcover, which was also effective in the early days of cancer growth, at a smaller volume and earlier stage.
q
There Research was published in the scientific journal Cancers.
Brain cancer: here are the advantages of the Dxcover liquid biopsy
According to Cancer Research UK, a 12,000 people in Britain are diagnosed with brain cancer each year and survival rates are 12% five years after diagnosis.
Read Also
- Citroën C3 Aircross, here are the Advanced Comfort seats | FormulaPassion.it Jul 19, 2021
- Criticism of Iker Jiménez is raining down for this tweet: “You do not have the minimum required ethics” – Explica .co Jun 29, 2021
- Is American Express raising premium card fees too soon? Jul 1, 2021
- Val-d’Oise: A new generation radar has appeared in Osny Nov 24, 2022
- Apple event April 20: what can you expect? Apr 19, 2021
- Eugenio Derbez denied Emilio Azcárraga about the rights of La Familia P. Luche: “Somebody explain to you” May 21, 2022
- Amazon launches Echo Auto, to add “the power of the Alexa to your car” Jul 16, 2020